Enpro Inc. Q1 2004 Financial Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2004, for Enpro Industries, Inc. (Enpro). Enpro is a manufacturer of engineered industrial products, including sealing products, metal polymer bearings, air compressors, and heavy-duty engines. The company operates through two reportable segments: Sealing Products and Engineered Products. As of May 5, 2004, there were 20,729,338 shares of common stock outstanding.
Key Financial Metrics
| Metric (in millions) | Q1 2004 | Q1 2003 |
|---|---|---|
| Sales | $213.8 | $184.0 |
| Operating Income | $19.7 | $12.6 |
| Net Income | $11.4 | $6.1 |
| Diluted EPS | $0.54 | $0.30 |
| Operating Cash Flow | $(15.7) | $(0.9) |
| Cash and Equivalents (End of Period) | $73.7 | $77.0 |
| Total Debt (Current + Long-term) | $167.5 | $170.2 |
| Asbestos Liability (Total) | $129.5 | $141.2 |
Note: Total Debt calculated as Current maturities of long-term debt ($2.8M) plus Long-term debt ($164.7M). Asbestos Liability includes current ($89.6M) and non-current ($39.9M) portions.
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 16% to $213.8 million, driven primarily by increased volume and favorable foreign exchange rates (specifically the Euro). The Sealing Products segment grew 16% to $95.6 million, while Engineered Products grew 16% to $118.6 million.
- Profitability: Net income surged 87% to $11.4 million. Segment profit increased 32% to $28.9 million. Gross margins improved to 32% (up 1.2 percentage points) due to cost reductions and favorable mix, offsetting rising raw material and energy costs.
- Cash Flow Deterioration: Operating cash flow turned significantly negative at $(15.7) million compared to $(0.9) million in the prior year. This was primarily due to a $16.8 million increase in asbestos-related payments net of insurance proceeds, driven by a dispute with insurance carriers delaying recoveries.
- One-Time Items: The company recorded a $1.5 million gain on the sale of a building. Unlike the prior year, there was no mark-to-market charge for call options on Goodrich stock.
Outlook, Risks, and Contingencies
- Guidance: Management expects Q2 2004 results to be similar to Q1 2004, noting that the strong Q1 performance may not show typical seasonal improvement. Full-year 2004 results are expected to be better than 2003 due to stronger markets and cost reductions, though new engine shipments may have limited earnings impact due to low margins.
- Asbestos Litigation: This remains the primary risk. There are 141,200 open asbestos cases. While the company has $799 million in available insurance coverage, a dispute with London market and U.S. carriers has delayed recoveries. Management anticipates net asbestos cash outflows for the first half of 2004 will be higher than the prior year but expects a decline for the full year once disputes are resolved.
- Crucible Materials: Enpro owns 44% of Crucible Materials Corporation through a trust expiring in May 2004. The investment is valued at zero on the balance sheet. If Enpro's ownership exceeds 50%, it could become liable for Crucible's unfunded pension obligations (estimated deficit of $22 million as of Dec 31, 2003).
- Capital Expenditures: CapEx is expected to increase significantly in 2004 due to investments in a new Quincy Compressor facility in China and a GGB plant in Slovakia.
Investor Verification Checklist
- Asbestos Insurance Dispute Resolution: Verify the status of the arbitration with London market carriers and the timeline for recovering the $38 million owed under the cap agreement plus $15.1 million in delinquent payments.
- Asbestos Cash Flow Impact: Monitor actual net asbestos cash outflows in Q2 to confirm if they align with management's expectation of a full-year decline.
- Crucible Trust Expiration: Assess the implications of the Ownership Trust expiring in May 2004 and the potential for Enpro to assume liability for Crucible's pension shortfall.
- Raw Material Costs: Track the impact of rising metal and energy prices on gross margins in subsequent quarters.
- Capital Spending Execution: Review progress and cost overruns on the new facilities in China and Slovakia.